Patents by Inventor Joseph D. Wright

Joseph D. Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200255643
    Abstract: A system for producing a functionalized olefinic-based polymer, the system comprising a polymerization zone for producing an olefinic-based polymer comprising a mixing section, a deliquifying section, and a quenching section, wherein at least one section of the polymerization zone has a defined cross-sectional area that continually decreases from a first end to a second end of said section; a devolatilization zone comprising a kneader or extruder, wherein said devolatilization zone is downstream of said polymerization zone and in fluid communication with said polymerization zone; and a functionalization zone downstream of said devolatilization zone and in fluid communication with said devolatilization zone.
    Type: Application
    Filed: December 9, 2016
    Publication date: August 13, 2020
    Inventors: Yu Feng Wang, Richard D. Hembree, Michael F. McDonald, JR., Joseph A. Maier, Richard C.M. Yeh, Leming Gu, Timothy D. Shaffer, Pamela J. Wright
  • Publication number: 20200143906
    Abstract: The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.
    Type: Application
    Filed: January 17, 2020
    Publication date: May 7, 2020
    Applicants: The United States of America,as represented by the Secretary,Department of Health and Human Services, British Columbia Cancer Agency Branch, Arizona Board of Regents on Behalf of the University of Arizona, Universitat de Barcelona, Hospital Clinic de Barcelona, The Cleveland Clinic Foundation, Board of Regents of the University of Nebraska, Oregon Health & Science University, Julius-Maximilians-University of Würzburg, Oslo University Hospital HF
    Inventors: Louis M. Staudt, George W. Wright, David William Scott, Joseph M. Connors, Randy D. Gascoyne, Lisa Rimsza, Elias Campo Guerri, Raymond Tubbs (Deceased), Timothy C. Greiner, James Robert Cook, Kai Fu, Paul Michael Williams, Chih-Jian Lih, Elaine S. Jaffe, Rita M. Braziel, Andreas Rosenwald, Erlend B. Smeland, Wing C. Chan, German Ott, Jan Delabie, Dennis Weisenburger
  • Patent number: 10607717
    Abstract: The invention is directed to methods for selecting a treatment option for an activated B cell-like diffuse large B cell lymphoma (ABC DLBCL) subject, a germinal center B cell-like diffuse large B cell lymphoma (GCB DLBCL) subject, a primary mediastinal B cell lymphoma (PMBL) subject, a Burkitt lymphoma (BL) subject, or a mantle cell lymphoma (MCL) subject by analyzing digital gene expression data obtained from the subject, e.g., from a biopsy sample.
    Type: Grant
    Filed: November 5, 2014
    Date of Patent: March 31, 2020
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, British Columbia Cancer Agency Branch, Arizona Board of Regents on behalf of the University of Arizona, Universitat de Barcelona, Hospital Clinic de Barcelona, The Cleveland Clinic Foundation, Board of Regents of the University of Nebraska, Oregon Health and Science University, Julius-Maximilians-University of Würzburg, Oslo University Hospital HF
    Inventors: Louis M. Staudt, George W. Wright, David William Scott, Joseph M. Connors, Randy D. Gascoyne, Lisa Rimsza, Elias Campo Guerri, Raymond Tubbs, Timothy C. Greiner, James Robert Cook, Kai Fu, Paul Michael Williams, Chih-Jian Lih, Elaine S. Jaffe, Rita M. Braziel, Andreas Rosenwald, Erlend B. Smeland, Wing C. Chan, German Ott, Jan Delabie, Dennis Weisenburger
  • Publication number: 20190153539
    Abstract: The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.
    Type: Application
    Filed: April 20, 2017
    Publication date: May 23, 2019
    Applicants: The United States of America, as represented by the secretary, Dep. of Health and Human Service, British Columbia Cancer Agency Branch, Julius-Maximilians - University of Würzburg, Oregon Health and Science University, Hospital Clinic de Barcelona, Universitat de Barcelona, Oslo University Hospital HF, Board of Regents of the University of Nebraska, The Cleveland Clinic Foundation, Mayo Foundation for Medical Education and Research
    Inventors: Louis M. Staudt, David William Scott, George W. Wright, Andreas Rosenwald, Pau Abrisqueta, Rita Braziel, Elias Campo Guerri, Wing C. Chan, Joseph M. Connors, Jan Delabie, Diego Villa, Kai Fu, Randy D. Gascoyne, Timothy Greiner, Elaine S. Jaffe, Pedro Jares, Anja Mottok, German Ott, Lisa M. Rimsza, Graham Slack, Dennis Weisenburger, Erlend B. Smeland, James Robert Cook
  • Patent number: 5550569
    Abstract: A desired image based on digital data is printed on a substrate. A subset of the digital data relating to a portion of the desired image is identified, wherein pixels associated with the digital data are of a predetermined spatial relationship with pixels intended to be of a different color as the pixels associated with the digital data. The subset of digital data is caused to activate a printhead adapted to emit ink of a first type. Data not of the subset of digital data is caused to activate a printhead adapted to emit ink of a second type, the ink of the first type being adapted to dry at a faster rate than the ink of the second type.
    Type: Grant
    Filed: April 12, 1994
    Date of Patent: August 27, 1996
    Assignee: Xerox Corporation
    Inventor: Joseph D. Wright
  • Patent number: 5301044
    Abstract: Taggants are incorporated into marking materials used to create images. Reproduction systems detect the taggants, and use the resulting information to control reproduction. The invention is particularly applicable to color correction, enhancement and translation; document identification; image preservation and highlighting; and document control and security.
    Type: Grant
    Filed: March 10, 1993
    Date of Patent: April 5, 1994
    Assignee: Xerox Corporation
    Inventor: Joseph D. Wright
  • Patent number: 5264315
    Abstract: A process for the continuous preparation of an encapsulated toner comprised of a core comprised of polymer and pigment encapsulated within a polymer shell, which process comprises continuously separately feeding an oil phase containing core monomers, oil soluble shell monomers and pigment and an aqueous phase containing surfactant into a continuous flowthrough mixing tank; homogenizing the aforementioned two phases to enable small oil droplets with an average diameter of from between about 3 to about 25 microns; overflowing the resulting droplets to at least one continuously stirred tank reactor while simultaneously feeding water soluble shell monomer to said stirred reactor to effect interfacial polymerization thereby causing shell formation; and thereafter allowing the encapsulated droplets to flow into a reactor or reactors and heating the reactor or reactors to effect free radical polymerization of the core monomers, followed by cooling, and isolating the said encapsulated toner.
    Type: Grant
    Filed: April 20, 1992
    Date of Patent: November 23, 1993
    Assignee: Xerox Corporation
    Inventors: Hock S. Tan, Hadi K. Mahabadi, Joseph D. Wright
  • Patent number: 5225900
    Abstract: Taggants are incorporated into marking materials used to create images. Reproduction systems detect the taggants, and use the resulting information to control reproduction. The invention is particularly applicable to color correction, enhancement and translation; document identification; image preservation and highlighting; and document control and security.
    Type: Grant
    Filed: December 31, 1990
    Date of Patent: July 6, 1993
    Assignee: Xerox Corporation
    Inventor: Joseph D. Wright
  • Patent number: 4727011
    Abstract: An improved process for the preparation of encapsulated toner compositions which comprises mixing in the absence of solvent a core monomer, an initiator, pigment particles, a first shell monomer, stabilizer, and water; thereafter adding a second shell monomer thereby enabling an interfacial polymerization reaction between the first, and second shell monomers; and subsequently affecting a free radical polymerization of the core monomer.
    Type: Grant
    Filed: October 16, 1986
    Date of Patent: February 23, 1988
    Assignee: Xerox Corporation
    Inventors: Hadi K. Mahabadi, Raj D. Patel, Steve W. Webb, Joseph D. Wright